PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
6368197-0	1983	[Antidepressive action, pharmacokinetic characteristics and biochemical properties of cimoxatone, a new reversible MAO-A inhibitor].	cimoxatone	86-96	monoamine oxidase A	Homo sapiens	115-120	
3045798-4	1988	If in vitro findings are considered, the most potent MAO-A inhibitor seems to be cimoxatone and the least potent toloxatone.	cimoxatone	81-91	monoamine oxidase A	Homo sapiens	53-58	
3045798-5	1988	After oral administration, however, cimoxatone, brofaromine and moclobemide appear to be about equally effective in inhibiting brain MAO-A.	cimoxatone	36-46	monoamine oxidase A	Homo sapiens	133-138	
6538844-0	1984	Effect of a reversible and selective MAO-A inhibitor (cimoxatone) on diurnal variation in plasma prolactin level in man.	cimoxatone	54-64	monoamine oxidase A	Homo sapiens	37-42	
6538844-3	1984	The effect of cimoxatone, a reversible, selective MAO-A inhibitor, on diurnal variation in plasma PRL level was investigated in healthy adults after a single 40 mg oral dose, as an indirect approach to investigating whether DA is preferentially a substrate for Type A or B MAO in man.	cimoxatone	14-24	monoamine oxidase A	Homo sapiens	50-55	
6698662-5	1984	MD 770222, which is also a selective and reversible inhibitor of MAO A although less potent than cimoxatone, is the major plasma metabolite and its plasma elimination half-life is about three times longer than cimoxatone.	cimoxatone	210-220	monoamine oxidase A	Homo sapiens	65-70